Treatment of psoriatic arthritis

The primary goal of treating patients with psoriatic arthritis (PsA) is to maximise health-related quality of life (HRQoL), through control of symptoms, prevention of structural damage, and normalization of function and social participation. Treatment goals in PsA should aim at reaching an acceptable disease state as agreed by both patient and physician. In 2009, minimal disease activity (MDA) criteria, the first potential target for treatment in PsA were published.